Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today ...
Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...
The first major conservative gathering since President Donald Trump’s second inauguration quickly became a stage for a symbolic homecoming: pardoned January 6 rioters, some of whom were ...
Viking Therapeutics (NASDAQ:VKTX) quickly soared 12% amid some renewed takeover speculation for the obesity drug maker. There's some renewed speculation Viking (NASDAQ:VKTX) may be a takeover ...
Starbucks Co. (NASDAQ:SBUX – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for shares of Starbucks in a research report issued to clients ...
Texas Longhorns head coach Steve Sarkisian confirmed what many expected to hear heading into the offseason. During an appearance on the Up and Adams Show, Sarkisian officially confirmed Arch ...
Spotlight Therapeutics, a startup with a bold vision for delivering CRISPR therapies into the body without the need for viral vectors or lipid nanoparticles, has … ...
"But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the ...
Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome, a severe form of epilepsy, outside the U.S., the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback